Pharma-Bio Serv, Inc. PBSV
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 398.46% | 132.51% | 84.73% | 87.08% | 89.97% |
| Total Depreciation and Amortization | -39.60% | -13.43% | 19.37% | 26.43% | 20.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 130.56% | 105.20% | 127.15% | 98.74% | 69.20% |
| Change in Net Operating Assets | -92.80% | 61.08% | 70.87% | -249.61% | -161.45% |
| Cash from Operations | 0.34% | 81.92% | 89.81% | 62.08% | -23.61% |
| Capital Expenditure | 96.02% | 95.65% | 94.27% | 95.80% | -14,745.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.47% | -7.51% | -93.10% | -21.53% | -104.74% |
| Cash from Investing | 30.76% | 1.77% | -92.89% | -7.75% | -107.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 47.75% | 12.17% | -727.50% | -180.36% | -85.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.13% | 0.13% | 0.13% | 0.13% | 0.13% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.75% | 0.27% | -1.55% | -1.03% | -0.46% |
| Foreign Exchange rate Adjustments | -76.18% | -10.22% | 249.49% | 351.41% | 146.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.80% | 78.71% | -272.70% | 7.90% | -170.19% |